QR-Code

Myocarditis as an immune-related adverse event following treatment with ipilimumab and nivolumab combination therapy for metastatic renal cell carcinoma: a case report

Abstract Background Immune checkpoint inhibitors are new immunotherapy drugs globally used for many malignancies, including renal cell carcinoma. Myocarditis as an immune-related adverse event is rare but highly fatal, suggesting that its frequency may be higher than reported. This paper describes a...

Ausführliche Beschreibung

Gespeichert in:
Hauptverfasser: Yasuyuki Miyauchi, Hirohito Naito, Hiroyuki Tsunemori, Ryosuke Tani, Yusuke Hasui, Yuichi Miyake, Tetsuo Minamino, Ryo Ishikawa, Yoshio Kushida, Reiji Haba, Mikio Sugimoto
Format: Artigo
Sprache:Inglês
Veröffentlicht: BMC 2021-10-01
Schriftenreihe:Journal of Medical Case Reports
Schlagworte:
Immunotherapy
Immune checkpoint inhibitors
Nivolumab
Ipilimumab
Immune-related adverse events
Myocarditis
Online-Zugang:https://doi.org/10.1186/s13256-021-03097-6
Tags: Tag hinzufügen
Keine Tags, Fügen Sie das erste Tag hinzu!

Ähnliche Einträge